Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06204406

Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy

Upper tract urothelial carcinoma (UTUC) is a rare malignant disease which accounts for 5-10% of urothelial carcinoma in the western world and 9%-30% in China. A…

China106 participantsStarted 2023-11-23

Treatment: Observational

All recent trials (2 shown)

Not Yet RecruitingNot Applicable

NCT07504939

Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma

UTUC is a cancer that develops in the lining of the kidney or ureter. The standard treatment is radical nephroureterectomy, which removes the kidney and ureter.…

China36 participantsStarted 2026-04-01

Treatment: SBRT